Title Differential expression of serum extracellular vesicle miRNAs in multiple sclerosis: disease-stage specificity and relevance to pathophysiology /
Authors Cuomo-Haymour, Nagiua ; Bergamini, Giorgio ; Russo, Giancarlo ; Kulic, Luka ; Knuesel, Irene ; Martin, Roland ; Huss, André ; Tumani, Hayrettin ; Otto, Markus ; Pryce, Christopher R
DOI 10.3390/ijms23031664
Full Text Download
Is Part of International journal of molecular sciences.. Basel : MDPI. 2022, vol. 23, no. 3, p. 115-127.. ISSN 1661-6596. eISSN 1422-0067
Keywords [eng] biomarker ; clinically isolated syndrome ; extracellular vesicles ; inflammation ; MicroRNA ; pathophysiology ; relapsing–remitting multiple sclerosis
Abstract [eng] Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system (CNS). Its first clinical presentation (clinically isolated syndrome, CIS) is often followed by the development of relapsing–remitting MS (RRMS). The periphery-to-CNS transmission of inflammatory molecules is a major pathophysiological pathway in MS. This could include signalling via extracellular vesicle (EV) microRNAs (miRNAs). In this study, we investigated the serum EV miRNome in CIS and RRMS patients and matched controls, with the aims to identify MS stage-specific differentially expressed miRNAs and investigate their biomarker potential and pathophysiological relevance. miRNA sequencing was conducted on serum EVs from CIS-remission, RRMS-relapse, and viral inflammatory CNS disorder patients, as well as from healthy and hospitalized controls. Differential expression analysis was conducted, followed by predictive power and target-pathway analysis. A moderate number of dysregulated serum EV miRNAs were identified in CIS-remission and RRMS-relapse patients, especially relative to healthy controls. Some of these miRNAs were also differentially expressed between the two MS stages and had biomarker potential for patient-control and CIS–RRMS separations. For the mRNA targets of the RRMS-relapse-specific EV miRNAs, biological processes inherent to MS pathophysiology were identified using in silico analysis. Study findings demonstrate that specific serum EV miRNAs have MS stage-specific biomarker potential and contribute to the identification of potential targets for novel, efficacious therapies.
Published Basel : MDPI
Type Journal article
Language English
Publication date 2022
CC license CC license description